Back
ACVC Premium Access

The predictors of frequent recurrent atrial fibrillation in patients with arterial hypertension

Session: Poster Session 5 - Pulmonary embolism, Arrhythmias and Sudden Cardiac Death, Imaging, Acute Aortic Syndrome - Arrhythmias & Sudden Cardiac Death
Topic: Atrial Fibrillation - Other
Speaker: Assistant Professor T. Danilevich (Vinnytsia, UA)
Event: Acute Cardiovascular Care 2018

Congress Session

0

About the speaker

Assistant Professor Tetiana Danilevich

Vinnytsia National Pirogov Medical University, Vinnytsia (Ukraine)
1 follower

27 more presentations in this session

Clinical and demographic differences between patients with positive and negative troponin who consulted with supraventricular tachycardia and thoracic pain in emergency services

Speaker: Associate Professor G. Mora (Bogota, CO)

Access
Abstract
0
Thumbnail

Usefulness of the martin scale to predict adverse events at 365 days in patients with syncope

Speaker: Associate Professor G. Mora (Bogota, CO)

Access
Abstract
0
Thumbnail

Characteristics of ventricular arrhythmias in young patients: does age make a difference?

Speaker: Miss R. Tomoaia (Cluj Napoca, RO)

Access
Abstract
Slides
0
Thumbnail

Transeosefageal ECHO during taking non-antagonists of vitamin K: excess labor or additional information?

Speaker: Doctor O. Dzhioeva (Moscow, RU)

Access
Abstract
Slides
0
Thumbnail

Cardioembolic stroke in a population of a district hospital: applicability of STAF score

Speaker: Doctor R. Carvalho (Leiria, PT)

Access
Abstract
0
Thumbnail

Access the full session

Poster Session 5 - Pulmonary embolism, Arrhythmias and Sudden Cardiac Death, Imaging, Acute Aortic Syndrome - Arrhythmias & Sudden Cardiac Death

Speakers: Assistant Professor T. Danilevich, Associate Professor G. Mora, Associate Professor G. Mora, Miss R. Tomoaia, Doctor O. Dzhioeva...
Access
0
Thumbnail

About the event

Image

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk